Search
Close this search box.
Search

IBM, Quest Diagnostics and MSK collaborate in new precision medicine service

IBM Watson Health, Quest Diagnostics and Memorial Sloan Kettering Cancer Center (MSK) are collaborating to launch ‘IBM Watson Genomics from Quest Diagnostics’, a new service that helps advance precision medicine. The service combines Quest Diagnostics tumour analysis and national access, with the cognitive computing of IBM’s Watson and the deep cancer treatment expertise of MSK.

Just like patients, cancers mutations all differ from one another. Precision medicine could make a huge difference in this regard: it makes it possible to find patient-specific —and thus, tumour specific— treatments and therapies. It however remains challenging for most clinicians to deliver on the promise of precision medicine, since it requires specialized expertise and a time-consuming interpretation of massive amounts of data. The new service may speed things up: it can quickly uncover highly personalized cancer treatment options—including options that previously may have remained unidentified.

Patient-specific treatment

To start the process, the treating oncologist or other physician will send a patient’s tumour biopsy tissue to Quest Diagnostics. Here, pathologists will prepare the tissue sample for genomic sequencing. Scientists at Quest will then sequence the genes, using sequencing technologies. They will feed the resulting genetic file, in which mutations are reveal, into Watson.

Watson will then compare the data against its clinical, scientific and pharmacological databases and rules created by leading oncologists. It will search for potential treatment options, targeted therapies and clinical trials, that match the patient’s individual tumour mutations. A Quest pathologist will review and validate the results and prepare a report to send back to the treating physician.

Comparing literature

Watson for Genomics ingests approximately 10,000 scientific articles and 100 new clinical trials every month. MSK will provide Watson with the knowledge from OncoKB (http://oncokb.org/#/). Comparison of literature that may take medical experts weeks to prepare can now be completed in significantly less time.

The databases must be routinely updated to account for rapidly evolving scientific discoveries, available drug therapies and appropriate clinical trials, especially for patients for whom no therapy is indicated. These patients could, thanks to the new service, potentially benefit from the world’s growing body of knowledge about this disease.

The launch marks the first time that Watson for Genomics has been made widely available to patients and physicians across the country. Quest Diagnostics now extends these capabilities to thousands of the country’s oncologists, who provide an estimated 70 percent of cancer care in the United States. The Broad Institute of MIT and Harvard will provide additional genome sequencing capabilities as part of the collaboration.

Whixx

ICT&health World Conference 2024

Experience the future of healthcare at the ICT&health World Conference from May 14th to 16th, 2024!
Secure your ticket now and immerse yourself in groundbreaking technologies and innovative solutions.
Engage with fellow experts and explore the power of global collaborations.

Share this article!

Read also
Balancing regulatory compliance with seamless adoption, healthcare navigates the integration of AI solutions.
A guide to implementing AI in healthcare amid the EU AI Act
AmyWebb-Stephen-Olker
Futurist Amy Webb claims that wearables will evolve into "connectables"
Digital health solutions empower patients to better manage their health and integrate care into their daily lives.
How to improve Digital Patient Engagement to streamline workflows
For people with diabetes, inaccurate blood glucose measurements can lead to errors in diabetes management, including taking the wrong dose of insulin, sulfonylureas, or other medications that can rapidly lower blood glucose.
Smartwatches measuring glucose level: Harmful but easy to buy fake innovations
How to introduce innovation and AI in healthcare organizations if there is no business model for prevention and quality – Our interview with Professor Ran Balicer, the Chief Innovation Officer at Clalit Health Services and founding Director of Clalit Research Institute.
I see no legitimate rationale for delaying the digital transformation in healthcare
Pioneering Cardiac Arrest Detection for Enhanced Survival.
CardioWatch Revolutionizes Cardiac Arrest Detection
Dr. Oscar Díaz-Cambronero, Head of Perioperative Medicine Department at La Fe Hospital, spearheads innovative telemonitoring initiatives revolutionizing patient care
Smartwatches Saving Lives Inside and Outside the Hospital
EIT 2024
EIT Awards 2024. Two European startups are revolutionizing the treatment of cardiovascular diseases
Bertrand Piccard, Swiss explorer and founder of the Solar Impulse Foundation
EIT Summit 2024. What are the trigger points that drive or inhibit innovation?
MMC pioneers wireless monitoring for premature infants with the innovative Bambi Belt, revolutionizing care with improved comfort and mobility.
Wireless Monitoring of Vital Signs in Premature Infants at Máxima MC
Follow us